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Abstract 
 
Although both the α- and β-domains of intrinsic factor (IF) have been 
previously expressed, the full crystal structure of the protein has yet to be 
reported. The purpose of this research is to (1) express IF in order to obtain a 
complete crystal structure and (2) utilize a mutant form of IF in order to 
orally deliver rotavirus to the ileum. The first goal of this research is to 
express IF in the yeast Pichia pastoris. The second goal is to express a K159D 
IF mutant protein. K159 of IF plays a role in salt bridge formation between IF 
and the CUB6 domain of cubilin, a critical receptor for vitamin B12 enterocyte 
passage. The third goal is to express a Q201A IF mutant protein. Q201 of 
intrinsic factor plays a role in the formation of hydrogen bonding between IF 
and the CUB6 domain of cubilin. We hypothesize the mutants will either 
prevent binding to cubilin or allow binding, but not allow for receptor-
mediated endocytosis. Utilizing the vitamin B12 pathway with the K159D or 
Q201A mutated IF will allow oral delivery of antigens, such as the rotavirus 
vaccine, to the ileum where they can trigger an IgA immune response.  
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I. Introduction 
 
Vitamin B12 Pathway: Vitamin B12 (B12), also known as cobalamin, is a  
water-soluble vitamin with a  molecular weight of 1355.3 required for blood 
cell formation, brain function, and DNA synthesis1. It is found in animal 
products such as meat, fish, and milk1. Because of its large size, B12 is not 
absorbed through the small intestine1. As a result, it requires a specific 
pathway to enter the blood serum2. The B12 pathway begins when the dietary 
source of B12 is broken down in the mouth (Figure 1). In the mouth it is 
bound by haptocorrin (HC), which brings it through the stomach and into the 
duodenum2. HC then releases B12 through the action by pancreatic proteases 
and an increase in pH from about 2 to 5.51. Intrinsic factor (IF) then binds to 
the B12 and brings it into the ileum3. Once in the ileum, the B12-IF complex 
binds to the cubilin receptor, which is located on the surface of the intestinal 
cells4. The –Cub-IF-B12 complex is then transferred across the cell through 
receptor-mediated endocytosis in association with the transmembrane 
protein amnionless3. Once transferred, IF is cleaved by cathepsin L and the 
free B12 is picked up by transcobalamin II (TC II) and ultimately delivered to 
the blood serum1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Dietary uptake pathway of B
mutation will prevent B
vitamin B12; IF: intrinsic factor; CB: cubilin; AM: amnionless).
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Figure 2. Crystal structure of intrinsic factor missing linker between α and β 
domains; Blue: α-domain, Red: β-domain, Green: Vitamin B12. Image taken 
from reference 2 with permission (Alpers et. al.) 
 
Cubilin-IF-B12 Complex: Cubilin (CUB) is the key receptor for intrinsic 
factor-B12 complexes3. The binding to CUB initiates receptor-mediated 
endocytosis6. The CUB5-8 domain of CUB interacts with IF-B123. The CUB6 
binding site was shown to be especially important in allowing for receptor-
mediated endocytosis to occur3. The CUB6 binding site is located on the α –
domain of IF3. This binding site involves residues from helices α-7 and α-9 
and the loop region between α-5 and α-63. Both domains of IF recognize 
CUB6 and CUB8 through a long, positively charged side chain which forms 
electrostatic interactions with the glutamate and aspartate residues in the 
binding sites of the CUB domains (Figure 3)3. The K159 of IF plays a role in 
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salt bridge formation between the IF-B12 complex and cubilin3. The Q201 of 
IF plays a role in hydrogen bonding with the CUB6 domain3. By mutating 
these regions to decrease IF-B12 and cubilin affinity, receptor-mediated 
endocytosis may be disrupted. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Left: CUB5–8–IF–Cbl complex. CUB (blue), IF (green), Cbl 
(pink). Right: Interactions between IF and CUB6 binding domain. Image taken 
from reference 3 with permission (Andersen et al.). 
 
KM71 Pichia pastoris Cells: Pichia pastoris is a species of methylotrophic 
yeast, meaning it is able to reduce carbon compounds11. It is frequently used 
as an expression system for proteins because it has a high growth rate11. A 
secretion signal, S. cerevisiae α factor prepropeptide,  was put into P. pastoris 
in order to allow the protein being expressed to be secreted into the media 
rather than staying within the yeast cells12. P. pastoris has two alcohol 
oxidase genes, AOX1 and AOX2, which allow P. pastoris to use methanol as an 
energy source as well as an inducer12. P. pastoris metabolizes methanol 
through the use of alcohol oxidases, which creates hydrogen peroxide as well 
as hydroyxmethyalene13. The hydroxymethyalene is sent through cycles such 
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as GAP and DHA13. In order to avoid hydrogen peroxide toxicity, peroxisomes 
cleave the hydroxymethyalene to produce ½ O2 and H2O13. 
 KM71 P. pastoris cells were specifically chosen for the MUTs 
phenotype. The MUTs phenotype means that these colonies grow slower than 
the ones without the mutations, and thus can be used for selection of 
colonies11. There is a slow growth phenotype because of a mutant aox1 
locus11. 
pPIC9: The vector used for cloning was pPIC9 (Figure 4). pPIC9 is an 8000 
base pair vector containing both a 5’ and 3’ AOX1 region14. The vector is 
ampicillin (amp) resistant and has multiple cloning sites14. pPIC9 is a shuttle 
vector, meaning it can operate in more than one organism14. pPIC9 can be cut 
by XhoI, SnaB, EcoRI, AvrII, and NotI14 and also allows for secretion of the 
gene being expressed14. In order to insert at the AOX1 region, pPIC9 must be 
linearized with SacI, which generates the MUTs in KM71 Pichia pastoris 
cells14.  
DH5α E. coli Cells: DH5α E. coli cells are chemically competent and result in 
high transformation efficiency, up to 1x106 transformants/μg15. The cells are 
used for efficient transformation of large plamids15. 
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II. Cloning, Expression, and Purification of K159D IF Mutant 
 
Introduction: K159 of IF plays a role in the salt bridge formation between IF 
and the CUB6 domain of cubilin3. By mutating the lysine to an aspartic acid, 
we hope to disrupt the salt bridge formation, and as a result, disrupt the 
receptor-mediated endocytosis of IF in the B12 pathway. Changing the 
positively charged lysine to a negatively charged aspartic acid should disrupt 
salt bridge formation. 
Site-Directed Mutagenesis: In order to create the K159D mutant, site-
directed mutagenesis was conducted. Two nucleotides from AAA were 
changed to GAT, in order to mutate the K159 to an aspartic acid. A master 
mix was made consisting of 0.5 μL of pfu buffer, 1 μL of dNTP, 0.37 μL FWD 
primer, 0.47 μL REV primer, 1 μL of pfu turbo polymerase, 1 μL of DMSO, and 
29.16 μL of dH2O. Polymerase chain reactions (PCR) mixtures of 5 ng/μL, 10 
ng/μL, 25 ng/μL, and 50 ng/μL were created using 40 μL of master mix and 
their respective volumes of template DNA: 1 μL, 2 μL, 5 μL, and 10 μL. Water 
was added to each tube to bring the final volumes to 50 μL. The primers 
(Figure 5) were designed in order to have a sequence that was the reverse 
complement of the region of DNA being mutated. They were also created to 
have a melting temperature between 55-65 °C.  
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K159D Forward: 
5’CTATCGCTGTTAGATTTGCTGATACTTTGTTGGCTAACTCCTC3’  
K159D Reverse:  
5’ GAGGAGTTAGCCAACAAAGTATCAGCAAATCTAACAGCG 3’ 
Figure 5. Forward and Reverse Primers for K159D Site Directed Mutagenesis 
 
The PCR conditions can be seen in Table 1. The PCR was run for 18 cycles 
because two nucleotides were being mutated. The annealing temperature of 
62 °C was chosen by averaging the two primer melting temperatures and 
subtracting 5 °C. Elongation was done at 72 °C in order for the pfu turbo 
polymerase to act most efficiently. 
Segment Cycles Temperature Time 
1 1 95 °C 30 s 
18 18 95 °C 30 s 
  62 °C 1 min 
  72 °C 4 min 
Table 1. PCR Setup for K159D Site-Directed Mutagenesis 
 After the PCR was run, 1 μL of DpnI was added to each tube in order to 
get rid of the methylated parent DNA. The tubes were then incubated for 1 
hour at 37 °C. 
Chemical Transformation into DH5α Cells: 50 μL of chemically competent 
DH5α E. coli cells were thawed on ice. 2 μL of each PCR mixture was added to 
a subsequent chemically competent cell tube. The tubes were left on ice for 
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30 minutes and then heat shocked at 42 °C in order to allow the plasmid to 
enter the cells. 500 μL of SOC broth was added to each tube and they were 
incubated for an hour at 37 °C to allow the cells to grow. Plates were 
streaked with each of the mixtures and then incubated overnight at 37 °C. 
 The next day, there were multiple colonies on all of the plates. 10 
colonies were picked and grown overnight in a shaker at 350 rpm at 37 °C in 
50 mL of LB with 5 μL of ampicillin (amp). The DNA was extracted from the 
cells using Wizard Plus SV Miniprep DNA Purification Method using the 
centrifugation protocol. The DNA sequences of the ten colonies were 
confirmed by sequencing. 
Triple Digestion of pPIC9: pPIC9 was triply digested using EcoRI and NotI-
hf in order to open it to insert the K159D gene. Lane 1 shows the closed 
vector, while Lanes 3-6 show the triply digested pPIC9 at about 8000 base 
pairs (Figure 6). In order to isolate the plasmid, a gel extraction was done 
using the QIAquick Gel Extraction Kit protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. 1% agarose gel of triply digested pPIC9. 
Lane 1: Ladder 
Lane 2: Control 
Lanes 3-6: Triply 
Digested pPIC9 
 
10000 bp 
8000 bp 
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Double Digested pUC57.K159D: The pUC57.K159D was doubly digested 
using EcoRI and NotI-hf to open the vector. As can be seen in Figure 7, Lane 1 
shows the pUC57.K159D vector. Lane 2 shows the doubly digested 
pUC57.K159D. The top band is the singly cut vector, the second band is the 
pUC57 vector, and the bottom band is the doubly digested K159D gene. The 
singly cut vector may have occurred because more vector was present than 
the enzymes could cut. The doubly digested gene (the bottom band) was 
extracted using the QIAquick Gel Extraction Kit protocol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 1% agarose gel of double digested pUC57.K159D. 
Ligation/Transformation: A molar ligation was performed at 16 °C 
overnight using molar ratios of 1:1, 3:1, 5:1, and 10:1. Then, a transformation 
was performed into chemically competent DH5α cells. Ampicillin plates were 
streaked and left to grow overnight at 37 °C. Eight colonies were picked for 
running a diagnostic agarose gel. As can be seen in Figure 8, the gel showed a 
Lane 1: Control 
Lane 2: Doubly 
Digested pUC57.K159D 
 
  1       2     
8000 bp- 
10000 bp- 
1500 bp- 
1200 bp- 
 
successful ligation in all colonies.
top band is the pPIC9 plasmid while the bottom band is the K159D mutant 
gene. Lanes 1 and 3
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Diagnostic 
K159D. 
 
Transformation into KM71 Cells: 
the plasmid must be linearized in order for a crossover to occur
used to linearize the DNA.
pPIC9.K159D vector whi
The closed vector is higher because closed, circular vectors move slower on 
gels than linearized DNA.
 
 
 
 
 
 
10000 bp
8000 bp
15
12
 Lanes 2-9 show the picked colonies. The 
 were confirmed by sequencing. 
1% agarose gel showing successful ligation of pPIC9 and 
In order to transform into 
 As shown in Figure 9, lane 1 shows
le lane 2 shows the linearized pPIC9.K159D vector.
 
 
00 bp 
00 bp 
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Figure 9. Linearized pPIC9.K159D cut with Sac I. 
 KM71 electrocompetent cells were thawed on ice. 10 μL of plasmid 
DNA was added to the cells. The mixture was electroporated at 1500 volts. 1 
mL of sorbitol was added to the cuvette and incubated for 1 hour at 30 °C. 
The cells were streaked onto buffered media for yeast (BMY) plates and 
incubated at 30 °C for five days until colonies were seen. 
 In order to see if the transformation was successful, a colony PCR was 
run. A colony was picked and swirled into a tube containing a PCR mixture. It 
was then placed in the PCR machine and sat overnight at 16 °C. As can be 
seen in Figure 10, all of the colonies showed that the DNA had been 
successfully inserted. However, Colony D was chosen for purification because 
it was the brightest and did not have any other bands in the lane. The faint 
bands at the bottom of the gel are known as primer dimer, because it is the 
two primers annealing to each other rather than the DNA. 
 
 
 
 
   A                        B 
A. Control 
B. Linearized 
pPIC9 
10000 bp 
8000 bp 
2000 bp- 
1500 bp- 
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Figure 10. Colony PCR of transformed KM71 Pichia pastoris cells. 
 
K159D Expression: In order to express the K159D protein, it was first 
induced in 10 mL of buffered media with glycerol for yeast (BMGY). After 18 
hours, 1 mL of this culture was transferred into 600 mL of BMGY. After 16 
hours the culture was centrifuged and resuspended in 200 mL of buffered 
media with methanol for yeast (BMMY). This was incubated at 30 °C for 48 
hours and then centrifuged. The media was then collected and filtered for 
purification through the use of fast protein liquid chromatography (FPLC). 
 In order to find the optimum time for growth, a time course 
experiment was run. 200 mL of BMMY media was incubated for 96 hours. 
After every 24 hours, 1 mL of media was removed. After 96 hours, all of the 1 
mL samples were run down an SDS-PAGE gel. As can be seen in Figure 11, 48 
hours was the optimum time for growing the K159D mutant. After 72 hours 
(Lane 8), all of the protein bands disappeared. The bands at 48 and 72 hours 
700 bp- 
600 bp- 
500 bp- 
2000 bp- 
1500 bp- 
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looked about the same darkness, resulting in growing the media for 48 hours 
for optimum expression. 
 The arrows on the right in Figure 11 show the three protein bands 
being looked for. The band at about 75 base pairs is glycosylated K159D, 
causing it to run higher than the 43.4 kDa of IF. The band at about 45 base 
pairs is unglycosylated K159D, at about the same height as unglycosylated IF. 
The band at about 25 base pairs is consistent with the α-domain of the 
K159D IF mutant 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. 12% SDS-PAGE gel of the K159D IF mutant time course over a 
period of 96 hours. 
 
  
K159D Purification: Fast protein liquid chromatography (FPLC) was used in 
order to purify the K195D protein from the media. 150 mL of the media was 
centrifuged at 8500 rpm for 1 hour at 4 °C. The media was then filtered and 
injected into the FPLC. A 5 mL Histrap Ni affinity column was used with a 
1. Ladder 
2. PIC 
3. Soluble 
4. Insoluble 
5. 24 h 
6. 48 h 
7. 72 h 
8. 96 h 
100 kDa 
75 kDa 
50 kDa 
37 KDa 
25 KDa 
 18
Peak 1 
Peak 2 
binding flow rate of 1 mL/min and a binding buffer containing 1x PBS (2.7 
mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4) and 0.5M NaCl. The elution flow 
rate was 0.5mL/min with an elution buffer containing 1x PBS, 0.5M NaCl, and 
1 M imidazole. The elution was run from 0-100% for 50 mL. The resulting 
data showed two peaks in the FPLC trace, as can be seen in Figure 12.  
 
 
 
 
 
 
 
 
 
 
 
Figure 12. FPLC trace of purified K159D showing two eluted peaks. 
  
 The corresponding SDS-PAGE gel (Figure 13) showed that peak 2 
contained bands that matched up with the IF control. The first band at about 
55 kDa is glycosylated K159D. The second band at about 46 kDa is 
unglycosylated K159D. The third band at about 30 kDa may be the α-domain 
of the intrinsic factor mutant, suggesting that some of the K159D IF is cleaved 
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between the α- and β- domains during expression. This means there may be 
proteases native to Pichia pastoris that can cleave IF. 
 
 
 
 
 
 
Figure 13. SDS-PAGE gel of FPLC purified K159D 
Confirmation of K159D Mutant: A western blot was done in order to show 
that K159D mutant had been expressed and purified. 750 μL of 5 mL elution 
fraction samples obtained from the FPLC were trichloro acetic acid (TCA) 
precipitated. Then the samples were run down a 12% SDS-PAGE gel for 90 
minutes at 150 V along with an IF control (2 mg dissolved in 100 μL of 10% 
SDS). The gel was stained overnight using commassie blue dye. The protein 
on the SDS-PAGE gel was transferred to a membrane using the iBlot system. 
The membrane was then immunoblotted using IF antibody (abcam, 
abcam91322 and Santacruz, sc2370) at a 1:500 dilution. A second western 
blot was also done using HisTag antibody (abcam, ab1187) at a 1:2000 
dilution. 
 
 
  
 
 
 
1. PIC (preinduction control) 
2. FT (flowthrough) 
3. Peak 1 
4. Peak 2 
5. IF control (2 mg/0.1 mL 
10% SDS) 
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Figure 14. Left: SDS-PAGE gel of membrane used for western blots; Right:  
His-tag antibody western 
 
Confocal Microscopy Uptake Studies: In order to see how the K159D 
mutant interacted with cubilin in vivo, confocal microscopy uptake studies 
were done. In order to prepare cultures for confocal uptake studies, purified 
protein was dialyzed in 0.1 M sodium bicarbonate buffer, pH 9.0 for 24 hours 
in 50 MWCO dialysis tubing. Alexa Fluor 488 was added in a 1:1 molar ration. 
Alexa Fluor 488 attaches to the primary amines of protein through a TFP 
ester moiety. The solution was rotated for 1 hr covered in aluminum foil. The 
protein and Alexa Fluor were then dialyzed in 1 L PBS, pH 7.4 for 24 hours 
three times. B12 was added in a 1:1 molar ratio and the samples were filtered 
and added to 200,000 cells/mL in confocal dishes. The cells were incubated 
for 45 minutes and then washed three times with PBS at pH 7.4 and three 
times with PBS at pH 3.  
 As can be seen in Figure 15, both the IF control and K159D were 
localized in the cytoplasm of the cells, indicating possible receptor-mediated 
endocytosis. The BN16 cells overexpress CUB and thus the IF would be seen 
L: Ladder 
1: crude K159D 
2: eluted K159D 
IF: control 
50 kDa 
 37 kDa 
 50 kDa 
 
37 kDa 
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inside the cells if it is endocytosed. We had hypothesized that mutating the 
K159 would disrupt receptor-mediated endocytosis, but from the confocal 
uptake studies it could be seen that this was not the case. We were looking 
for the K159D mutant to bind to the cubilin, but not be taken into the cells. As 
can be seen n Figure 11, the K159D protein is internalized, indicating K159D 
is not critical for binding despite its involvement in Ca2+ binding.  
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Right: Confocal images of IF inside BN16 cells visualized using 
Alexa Fluor 488. Left: Confocal images of K159D inside BN16 cells visualized 
using Alexa Fluor 488. 
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III. Cloning, Expression, and Purification of Q201A Mutant IF 
 
Introduction: Q201 of IF plays a role in the formation of hydrogen bonds 
between IF and the CUB6 domain of cubilin3. By mutating a different part of 
the binding site, we hope to disrupt the receptor-mediated endocytosis of IF 
in the vitamin B12 pathway. 
Site-Directed Mutagenesis:  In order to create the Q201A mutant, site-
directed mutagenesis was done. Two nucleotides were changed in order to 
mutate the Q201 to an alanine. A master mix was made consisting of 0.05 μL 
of pfu buffer, 1 μL of dNTP, 0.37 μL FWD primer, 0.47 μL REV primer, 1 μL of 
pfu turbo polymerase, 1 μL of DMSO, and 29.16 μL of dH2O. PCR mixtures of 5 
ng/μL, 10 ng/μL, 25 ng/μL, and 50 ng/μL were created using 40 μL of master 
mix and their respective volumes of template DNA: 1 μL, 2 μL, 5 μL, and 10 
μL. Water was added to each tube to bring the final volumes to 50 μL. The 
primers (Figure 16) were designed in order to have a sequence that was the 
reverse complement of the region of DNA being mutated. The primers were 
also created to have a melting temperature between 55-65 °C.  
FWD Primer: 
5’-GATACAGATCATTGTTCGGAGCAGTTTTGAAGGACATCGTTGA-3’ 
REV Primer: 
5’-GTCCTTCAAAACTGCTCCGAACAATGATCTGTATCCCTC-3’ 
 
Figure 16. Forward and reverse primers for Q201A mutagenesis. 
 
The PCR conditions can be seen in Table 2. The PCR was run for 18 cycles 
because two nucleotides were being mutated. The annealing temperature of 
62 °C was chosen by averaging the two primer melting temperatures and 
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subtracting 5 °C. The final stage was done at 72 °C in order for the pfu turbo 
polymerase to act most efficiently. 
Segment Cycles Temperature Time 
1 1 95 °C  30 s 
18 18 95 °C 
62 °C 
72 °C 
30 s 
1 min 
4 min 
 
Table 2. PCR conditions for Q201A site-directed mutagenesis. 
 After the PCR was run, 1 μL of DpnI was added to each tube in order to 
get rid of the methylated parent DNA. The tubes were then incubated for 1 
hour at 37 °C. 
Chemical Transformation into DH5α Cells: 50 μL of chemically competent 
DH5α E. coli cells were thawed on ice. 2 μL of each PCR mixture was added to 
a subsequent chemically competent cell tube. The tubes were left on ice for 
30 minutes and then heat shocked at 42 °C in order to allow the plasmid to 
enter the cells. 500 μL of SOC broth was added to each tube and they were 
incubated for an hour at 37 °C to allow the cells to grow. Plates were 
streaked with each of the mixtures and then incubated overnight at 37 °C. 
 The next day, there were multiple colonies on all of the plates. Six 
colonies were picked and grown overnight at 350 rpm at 37 °C in 50 mL of 
LB with 5 μL of amp. The DNA was extracted from the cells using Wizard Plus 
SV Miniprep DNA Purification Method using the centrifugation protocol. The 
DNA sequences of the six colonies were confirmed by sequencing. 
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Triple Digestion of pPIC9: pPIC 9 was triply digested using EcoRI and NotI-
hf in order to open it to insert the Q201A gene. Lane 1 shows the closed 
vector, while Lanes 3-6 show the triply digested pPIC9 at about 8000 base 
pairs (Figure 17). In order to isolate the plasmid, a gel extraction was done 
using the QIAquick Gel Extraction Kit protocol. 
Double Digested pUC57.Q201A: The pUC57.Q201A was doubly digested 
using EcoRI and NotI-hf to open the vector. As can be seen in Figure 17, Lane 
7 shows the pUC57.Q201A vector. Lanes 8-9 show the doubly digested 
pUC57.Q201A. The first band is the pUC57 vector, and the bottom band is the 
doubly digested Q201A gene. The doubly digested gene (the bottom band) 
was extracted using the QIAquick Gel Extraction Kit protocol.  
 
 
 
 
 
 
 
 
Figure 17. 1% agarose gel of triply digested pPIC9 and double digested 
pUC57.Q201A. 
 
 
Ligation/Transformation: A molar ligation was performed at 16 °C 
overnight using molar ratios of 1:1, 3:1, 5:1, and 10:1. Then, a transformation 
1. Ladder 
2. pPIC9 control 
3-6. Triple digested pPIC9 
7. Q201A control 
8-9. Double digested Q201A 
2000 bp- 
1500 bp- 
1200 bp- 
1000 bp- 
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was performed into chemically competent DH5 α cells. Ampicillin plates 
were streaked and left to grow overnight at 37 °C overnight. Eight colonies 
were picked for running a diagnostic agarose gel. As can be seen in Figure 18, 
the gel showed a successful ligation in all colonies except for colony 6. Lanes 
2-9 show the picked colonies. Colony 6 showed the pPIC9 vector at a much 
lower height than it should have been. The top band is the pPIC9 plasmid 
while the bottom band is the K159D mutant gene. Lanes 2 and 3 were 
confirmed by sequencing.  
 
 
 
 
 
 
 
Figure 18. Diagnostic gel showing successful ligation of pPIC9 plasmid and 
Q201A gene in lanes D and E. 
 
Transformation into KM71 P. pastoris Cells: In order to transform into P. 
pastoris, the plasmid must be linearized in order for a crossover to occur12. 
SacI was used to linearize the DNA.  
 KM71 electrocompetent cells were thawed on ice. 10 μL of plasmid 
DNA was added to the cells. The mixture was electroporated at 1500 volts. 1 
mL of sorbitol was added to the cuvette and incubated for 1 hour at 30 °C. 
12000 bp- 
 
2000 bp- 
 
1500 bp- 
 1200 bp- 
 1000 bp- 
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The cells were streaked onto BMY plates and incubated at 30 °C for five days 
until colonies were seen. 
 In order to see if the transformation was successful, a colony PCR was 
run. A colony was picked and swirled into a tube containing a PCR mixture. It 
was then placed in the PCR machine and sat overnight at 16 °C. As can be 
seen in Figure 19, only colonies D and E suggested successful 
transformations. Lane 1 was the control.  
 
 
 
 
 
 
 
 
 
Figure 19. Colony PCR of transformed KM71 Pichia pastoris cells. 
 
Q201A Expression: In order to express the Q201A protein, it was first 
induced in 10 mL of BMGY. After 18 hours, 1 mL of this culture was 
transferred into 600 mL of BMGY. After 16 hours the culture was centrifuged 
and resuspended in 200 mL of BMMY. The media was incubated at 30 °C for 
1      A     B     C      D    E      F      G 
1500 bp 
1200 bp 
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48 hours and then centrifuged. The media was then collected and filtered for 
purification. 
 In order to find the optimum time for growth, a time course 
experiment was run. 200 mL of BMMY media was incubated for 96 hours. 
After every 24 hours, 1 mL of media was removed. After 96 hours, all of the 1 
mL samples were run down an SDS-PAGE gel. 48 hours was the optimum 
time for growing the Q201A mutant. The bands at 48 and 72 hours looked 
about the same darkness, resulting in growing the media for 48 hours for 
optimum expression. The bands at 96 hours look a little darker, but not 
enough to increase the expression period by 48 hours. 
 
 
 
 
 
 
 
 
 
Figure 20. SDS-PAGE gel of the Q201A IF mutant time course over a period 
 of 96 hours. 
 
Q201A Purification: A fast protein liquid chromatography (FPLC) was used 
in order to purify the Q201A protein from the media. 150 mL of the media 
was centrifuged at 8500 rpm for 1 hour at 4 °C. The media was then filtered 
and run down the FPLC. A 5 mL Histrap Ni affinity column was used with a 
1          2          3   4    5   6    7    8 
Lane 1: Ladder 
Lane 2: PIC 
Lane 3: soluble 
Lane 4: insoluble 
Lane 5: 24h 
Lane 6: 48h 
Lane 7: 72h 
Lane 8: 96h 
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binding flow rate of 1 mL/min and a binding buffer containing 1x PBS (2.7 
mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4) and 0.5M NaCl. The elution flow 
rate was 0.5mL/min with an elution buffer containing 1x PBS, 0.5M NaCl, and 
1 M imidazole. A stepwise elution was done with three different percentages 
of elution buffer: 4, 10, and 25 percent. The resulting data showed three 
peaks as can be seen in Figure 21. 
 The first peak was eluted with 4% elution buffer. In the corresponding 
SDS-PAGE gel, see Figure 22, there were many bands, showing that the first 
peak was other stuff that had stuck to the column. The second peak was 
eluted with 10% elution buffer, and had bands showing the correct height for 
the IF mutant. The third peak was eluted with 25% elution buffer and did not 
show any bands on the SDS-PAGE with commassie staining. 
 
 
 
 
 
 
 
Figure 21. FPLC trace of Q201A stepwise elution. 
Confirmation of Q201A Mutant: A western blot was conducted in order to 
show that the Q201A mutant had been expressed and purified. 750 μL of 5 
mL elution fraction samples obtained from the FPLC were TCA precipitated. 
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Then the samples were run down a 12% SDS-PAGE gel for 90 minutes at 150 
V along with an IF control (2 mg dissolved in 100 μL of 10% SDS). The gel 
was stained overnight using commassie blue dye. Western blots were also 
performed on the samples obtained from the FPLC. The protein on the SDS-
PAGE gel was transferred to a membrane using the iBlot. The membrane was 
then immunoblotted using HisTag antibody (abcam, ab1187) at a 1:2000 
dilution. 
 As can be seen in Figure 22, bands at about 46 kDa appeared on the 
western blot in both the 4% elution and 10% elution peaks. In the 10% 
(lanes 8-10), the α fragment can also be seen at about 25 kDa.  
 
 
 
 
 
 
 
 
Figure 22. Left: SDS-PAGE gel of FPLC peaks of Q201A Right: His-tag western 
blot of Q201A 
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IV. Conclusion 
 
 In the future, the K159D confocal micrscopy has to be redone. Also, 
the Q201A confocal micrscopy has to be done. The IF, K159D, and Q201A 
proteins are being tested for specific cubilin binding in collaboration with 
Professor Mette Madsen, University of Aarhus, Denmark. Professor 
Madsens’s lab will look at the specific binding affinities between each of the 
mutants and cubilin, allowing us to compare them quantitatively rather than 
just through images on the confocal. 
 Research on the K159D and Q201A mutants will help to shed light on 
important intrinsic factor binding sites. By binding rotavirus to the mutants, 
a safer alternative to the current vaccine may be created, leading to better 
third-world access to the drug. Finally, utilizing the B12 uptake pathway in 
this way, it could become a delivery system for other vaccines, offering a new 
platform for drug delivery. 
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Capstone Summary 
  
 The vitamin B12 pathway is an important delivery mechanism for the 
body to absorb B125. Food containing B12, such as meat, is broken down in 
the mouth where the B12 is then picked up by the transport protein 
haptocorrin (HC)5. The HC-B12 complex goes through the stomach and HC is 
broken down by a change in pH and proteases5. B12 is picked up by IF and 
brought into the small intestine. The IF-B12 complex is then bound to cubilin 
(CUB) and transported into the epithelial cells of the small intestine3. The 
B12 is eventually delivered into the blood serum3. 
 In order to use this pathway for drug delivery, we had to create a 
mutant form of IF that would bind to cubilin but not enter the cell. This way, 
the drug would stay localized in the small intestine to trigger an immune 
response. It has been shown that the CUB5-8 binding domains are important 
for transporting the IF-B12 into the cell, especially the CUB6 and CUB8 
domains3. We examined the binding between the CUB6 domain of cubilin and 
IF and distinguished two amino acids that could be changed to disrupt 
binding. The first mutation was a K159D mutant, which changed the lysine of 
IF to an aspartic acid. This would disrupt salt bridge formation between 
cubilin and IF. The other mutation was a Q201A mutant, which changed the 
glutamine to an alanine. This would disrupt hydrogen bonding between 
cubilin and IF. 
 A site-directed mutagenesis was done in order to create both the 
K159D and Q201A mutants. Site-directed mutagenesis is a procedure in 
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which a specific area of a DNA molecule is mutated.  The IF DNA molecule 
was mixed with primers containing the mutations we were trying to create in 
the IF protein. A polymerase chain reaction (PCR) was run in order for the 
primers to bind to the IF DNA molecule and make many copies of it that 
contained the mutations. The original non-mutated IF DNA was removed 
through the use of the enzyme DpnI, which gets rid of methylated DNA. We 
confirmed the correct mutations were made and that no other mutations had 
occurred during the process by sending off the samples for sequencing. 
 Next, we needed to express both the K159D and Q201A mutants so 
that we could get enough of each for experiments. This was done through the 
use of Pichia pastoris, a yeast. The K159D and Q201A mutants were placed 
inside the yeast cells through the use of a vector. As the yeast grew, it also 
secreted the mutant proteins into the media. 
 The IF mutants were expressed in Pichia pastoris cells, which are 
yeast cells. The DNA was inserted into the cells and grown up in media, while 
also secreting the IF mutants into the media. However, the protein is mixed 
in with all of the nutrients and other things the yeast is secreting while 
growing. As a result, we had to purify the media in order to collect only the 
protein. This was done through the use of fast protein liquid chromatography 
(FPLC). The media is injected into the FPLC and run through a nickel affinity 
column. Both of the IF mutants are tagged with six histidine residues at the 
end of their amino acid chains, allowing them to bind to the nickel column 
while everything else is flushed away. In order to collect the protein, the 
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column is washed with a buffer containing imidazole. Imidazole has a similar 
structure to histidine; allowing it to bind to the nickel column and in the 
process, knock off the IF mutants. 
 In order to ensure we were expressing and purifying the correct 
proteins, we ran two experiments to examine the samples. The first method 
we used was running an SDS-PAGE gel. The SDS-PAGE gel separates proteins 
based on their size. By running our samples on the gel along with an IF 
control, we were able to compare the bands of our protein to the band of the 
IF protein. IF is about 45 kDa and the mutants should appear at the same 
height, as one amino acid switch will not affect its size by very much. Both 
proteins showed up at the correct heights. However, there was also a higher 
band at about 55 kDa and a lower band at about 30 kDa. The 55 kDa band is 
glycosylated IF, meaning it has had sugars added to it, while the lower band 
is the α domain of IF. 
 The other test that we performed on the purified samples was a 
western blot. Another SDS-PAGE gel was run and the protein bands were 
transferred to a membrane. Antibodies specific to IF are washed over the 
membrane and bind to anything with the IF binding site for the antibody. A 
second antibody is washed over the membrane that will bind to the first 
antibody to enhance the signal. These sites are then detected by spraying a 
luminescent solution over the membrane and then transferring it to a film. 
The film is developed and the resulting bands can be seen on it. As with the 
SDS-PAGE gel, an IF control was run with the samples so that we could 
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compare bands. As with the SDS-PAGE gel, the bands matched and also 
ensured that the IF mutants were being created, as the antibodies are specific 
only to IF. 
 Confocal studies allowed us to see how the mutants interacted with 
cubilin. The K159D protein was dyed green so that we could track their 
interactions with BN16 cells, which overexpress cubilin. Preliminary 
experiments showed that the protein entered the cell, which is not what we 
had attempted to do. As previously mentioned, we had wanted to stop the 
proteins from entering the cells.  
 However, future work entails redoing this experiment with both 
mutants as well as sending off samples to a lab in Denmark. They will look at 
the specific binding affinities between each of the mutants and cubilin, 
allowing us to compare them quantitatively rather than just through images 
on the confocal. 
 Research on the K159D, Q201A, and K159D Q201A mutants will help 
to shed light on important intrinsic factor binding sites. By binding rotavirus 
to the mutants, a safer alternative to the current vaccine may be created, 
leading to better third-world access to the drug. Finally, utilizing the B12 
uptake pathway in this way, it could become a delivery system for other 
vaccines, offering a new platform for drug delivery. 
 
